Showing results (511-520 of 9,974) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|February 18, 2011
Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndromeJiri Pavlu, Julie Emmerson, Alexandra J Marks, et al.Leukemia & Lymphoma|February 2, 2011
JAK2V617F mutation is associated with special alleles in essential thrombocythemiaHui-Hua Hsiao, Yi-Chang Liu, Hui-Jen Tsai, et al.Leukemia & Lymphoma|February 2, 2011
Cyclin D1 positive diffuse large B-cell lymphoma is a post-germinal center-type lymphoma without alterations in the CCND1 gene locusTeresa Vela-Chávez, Patrick Adam, Marcus Kremer, et al.Leukemia & Lymphoma|February 2, 2011
Hypoxia-associated protein expression in primary central nervous system diffuse large B-cell lymphoma: does it predict prognosis?Jung A Kim, Seok Jin Kim, In-Gu Do, et al.Leukemia & Lymphoma|February 2, 2011
Intermediate prognosis of 6q deletion in chronic lymphocytic leukemiaDong-Mei Wang, Kou-Rong Miao, Lei Fan, et al.Leukemia & Lymphoma|January 29, 2011
Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitorNakhle S Saba, Laura S LevyLeukemia & Lymphoma|January 12, 2011
Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cellsWolfgang Kern, Ulrike Bacher, Claudia Haferlach, et al.Leukemia & Lymphoma|February 9, 2011
Chronic myeloid leukemia cells refractory/resistant to tyrosine kinase inhibitors are genetically unstable and may cause relapse and malignant progression to the terminal disease stateTomasz SkorskiLeukemia & Lymphoma|February 9, 2011
New developments in the treatment of chronic myeloid leukemia and Philadelphia-positive acute lymphoblastic leukemiaAmber Fullmer, Hagop Kantarjian, Jorge Cortes, et al.Leukemia & Lymphoma|January 22, 2011
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitorsBruno Calabretta, Paolo SalomoniPageof 998